Real-time bioluminescence imaging of mycobacteria with Akaluc: a novel method for monitoring drug efficacy
Open Access
- 15 May 2026
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Tuberculosis (TB) still threatens human life despite the availability of childhood vaccination and modern treatment regimens due to the emergence of tuberculosis with extended resistance profiles. The mouse active TB model remains the gold standard for evaluating anti-TB drugs and vaccines. However, in vivo experiments raise ethical concerns and are time-consuming. We established an Akaluc-based bioluminescence platform to enable rapid drug screening in culture media and THP‑1 cells. Codon-optimized Akaluc expression in mycobacteria was accomplished by assortment of vectors and promoters. Bioluminescence kinetics were evaluated in culture media and THP‑1 cells with or without drug treatment, and optimized by adjusting time points and substrate concentrations. TokeOni at a concentration of 10 nM/100 µL produced the highest bioluminescence compared to other tested concentrations and substrates. Among the tested promoter-plasmid constructs, the Ag85B promoter in pMV261 generated the strongest bioluminescence in Mycobacterium smegmatis and Mycobacterium bovis. Bioluminescence fluctuated with bacterial growth, peaking during the log phase and gradually declining during the stationary phase. A positive correlation was observed between bioluminescence and CFU reduction in vitro upon treatment with sensitive drugs.Keywords
Funding Information
- Japan Society for the Promotion of Science (24K10216)
- Japan Society for the Promotion of Science (23K06543)
- Japan Society for the Promotion of Science (25K18794)
- Japan Society for the Promotion of Science (21KK0136)
- AMED-CREST (22gm1610009)
- Japan Agency for Medical Research and Development (JP223fa627005)
This publication has 59 references indexed in Scilit:
- Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infectioniScience, 2024
- M. tuberculosis relies on trace oxygen to maintain energy homeostasis and survive in hypoxic environmentsCell Reports, 2023
- Multiplexed bioluminescence imaging with a substrate unmixing platformCell Chemical Biology, 2022
- Mycobacterium tuberculosis Infection of THP-1 Cells: A Model for High Content Analysis of Intracellular Growth and Drug Susceptibility2022
- Firefly luciferase offers superior performance to AkaLuc for tracking the fate of administered cell therapiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Evaluating Brightness and Spectral Properties of Click Beetle and Firefly Luciferases Using Luciferin Analogues: Identification of Preferred Pairings of Luciferase and Substrate for In Vivo Bioluminescence ImagingMolecular Imaging and Biology, 2020
- Evaluation of the intracellular activity of drugs against Mycobacterium abscessus using a THP-1 macrophage modelJournal of Microbiological Methods, 2018
- A luciferase-based assay for rapid assessment of drug activity against Mycobacterium tuberculosis including monitoring of macrophage viabilityJournal of Microbiological Methods, 2014
- Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunityMicrobes and Infection, 2009
- Optimisation of a mycobacterial replicon increases foreign antigen expression in mycobacteriaTuberculosis, 2009